Skip to content

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

French African Pediatric Oncology Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03803735
Acronym
RFAOP
Enrollment
10000
Registered
2019-01-15
Start date
2016-01-01
Completion date
2030-12-31
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Cancer

Brief summary

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population. Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.

Detailed description

This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome. The register also collects information on vital status, treatment abandonment and loss to follow-up. Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.

Interventions

None listed

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris
CollaboratorOTHER
French Africa Pediatric Oncology Group
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years

Inclusion criteria

1. Any child presenting at any one of the participating units for treatment 2. Any child with any type of cancer 3. Any child or adolescent less than 18 years of age.

Exclusion criteria

1. No cancer found 2. Age greater than 18 years -

Design outcomes

Primary

MeasureTime frameDescription
Number of children with a suspicion of any type of cancer in a given unitin any 12 month periodNumber of children with details of : 1. the type of cancer 2. the stage of the identified cancer coming into a given unit
VITAL STATUS:in any 12 month periodDead or alive 1. The number of children living 2. the number of children dead
Illness statusin any 12 month period1. The number of children relapsed, 2. The number of children whos illness has progressed.
Treatment Statusin any 12 month period1. The number of children who had treatment administered, 2. The number of children who abandoned treatment

Countries

Burkina Faso, Cameroon, Côte d’Ivoire, Democratic Republic of the Congo, France, Gabon, Madagascar, Mali, Mauritania, Niger, Senegal, Togo

Contacts

Primary ContactBrenda MALLON, MSC
brenda.mallon@gustaveroussy.fr+ 33142115411
Backup ContactCatherine PATTE, DR
catherine.patte@gustaveroussy.fr+ 33142116560

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026